NEUROPHET Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	2,615	2,216
Revenue Growth (YoY)	18.00%	-
Cost of Revenue	3.91	1.27
Gross Profit	2,611	2,215
Selling, General & Admin	12,337	9,739
Research & Development	5,276	5,987
Amortization of Goodwill & Intangibles	148.53	141.42
Other Operating Expenses	108.99	62.28
Operating Expenses	19,160	16,864
Operating Income	-16,549	-14,649
Interest Expense	-920.64	-3,614
Interest & Investment Income	413.26	468.72
Currency Exchange Gain (Loss)	-9.89	-17.5
Other Non Operating Income (Expenses)	-5,323	2,713
EBT Excluding Unusual Items	-22,389	-15,098
Gain (Loss) on Sale of Assets	-0.08	-3.48
Pretax Income	-22,389	-15,101
Net Income	-22,389	-15,101
Net Income to Common	-22,389	-15,101
Shares Outstanding (Basic)	10	4
Shares Outstanding (Diluted)	10	4
Shares Change (YoY)	163.48%	-
EPS (Basic)	-2302.00	-4091.00
EPS (Diluted)	-2302.00	-4091.00
Free Cash Flow	-15,332	-12,862
Free Cash Flow Per Share	-1576.43	-3484.24
Gross Margin	99.85%	99.94%
Operating Margin	-632.84%	-660.98%
Profit Margin	-856.15%	-681.41%
Free Cash Flow Margin	-586.30%	-580.35%
EBITDA	-15,439	-13,554
D&A For EBITDA	1,110	1,095
EBIT	-16,549	-14,649
Advertising Expenses	799.23	919.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.